Proteomics: a novel tool to unravel the patho-physiology of uraemia.
about
Effect of membrane permeability on survival of hemodialysis patientsProteomic Investigations into Hemodialysis TherapyDiscovery and validation of urinary biomarkers for prostate cancerProteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and pmma) during hemodialysis treatment using SELDI-TOF-MS.Proteomics in renal research.Proteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples.High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urineDialysis Procedures Alter Metabolic Conditions.Alteration of human blood cell transcriptome in uremia.The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis.State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacyProteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.Erythrocyte glutathione transferase: a new biomarker for hemodialysis adequacy, overcoming the Kt/V(urea) dogma?Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis.What is uremia? Retention versus oxidation.Online hemodiafiltration.The epidemic of cardio-vascular disease in renal failure: where does it come from, where do we go?Inconsistency of reported uremic toxin concentrations.Uremic toxins: do we know enough to explain uremia?Considerations in the statistical analysis of hemodialysis patient survivalUpdate of uremic toxin research by mass spectrometry.Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.Examining hemodialyzer membrane performance using proteomic technologies.Biomarkers for Renal Disease and Uremic Toxins
P2860
Q24642458-08DC8B76-10C7-46B1-B4AC-14CD425C9793Q26774276-C93503F1-50A7-4758-B555-867CC7A83EF1Q30438582-B2847B0F-9EE9-4AED-BD92-6A72B897F87AQ30820750-8990CB8E-CC32-44E2-A0E2-547F3FB21B30Q33263714-C0592982-252C-4175-91AD-C2F2F56E5969Q33364699-2B9BAA93-D6EB-44B8-BB2F-5BA2B75C8C0EQ33610197-CDA23938-839E-4F18-9659-F7678E1546E4Q33851814-573E0A02-4CCF-4E1E-9A71-FD0161E5A698Q34786583-52E5D38A-24BF-4103-8D1C-BD821E402D98Q35071374-BE7F808A-7A5B-479B-AD5E-D0740868F839Q35570959-3227D264-633B-45A1-8A8F-CF2C1B4D7F5CQ35891553-06AC8CA0-CD62-45F4-8D4B-F0ECCC6FE477Q36184802-4783B7F6-E6FA-4387-AA6D-6E4818822716Q36211438-459F117C-83D5-4607-B253-0F3197530BC2Q36279044-4ACD8D8C-829C-4B5E-9069-70B4263C10C6Q36345527-50989C3A-2FAC-4F14-B22C-6EA760582C3AQ36566711-B002AAA3-431A-45A0-9D48-9938B2D0E3FEQ36714285-94A289A9-595D-4431-822B-A9581FCA7497Q36890915-8F92FCE3-F4BC-4842-BD21-A20902350215Q37053439-D7FC1897-69AA-4A54-8E46-8FE715D4BE62Q37330580-51012C23-2A08-4D8C-8869-3BBA1CA03A4FQ37844014-B2F7D744-589F-4102-9F86-A74CA2C5C6E6Q37951798-BD555D4B-EE83-4E1A-ADF0-23680051E877Q47121473-B156BB19-0F0B-4A65-AF67-CEB5B7DDF8F9Q57712082-45E8239C-9889-4DA9-AF26-48B7611337A6
P2860
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@ast
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@en
type
label
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@ast
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@en
prefLabel
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@ast
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@en
P2093
P2860
P356
P1476
Proteomics: a novel tool to unravel the patho-physiology of uraemia.
@en
P2093
Eva M Weissinger
Michael Walden
Natalie Meert
Raymond C Vanholder
Rita De Smet
Thorsten Kaiser
P2860
P304
P356
10.1093/NDT/GFH509
P407
P577
2004-10-19T00:00:00Z